Carcinoma of Unknown Primary

Protox acquires research program from MedicennaCNW Telbec (Communiqués de presse), Canada - 3 hours agoIn addition, a Phase I trial has been completed for PRX321 to treat patients with renal cell carcinoma and non-small cell lung cancer. …

Read full story